Ajanta Pharma (BOM:532331) Inventories, Work In Process: ₹0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:532331 Ajanta Pharma Ltd BOM:532331
95 GF Score
Price ₹3,480.95
GF Value ₹3,348.50
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Ajanta Pharma Inventories, Work In Process?

Ajanta Pharma BOM:532331 -0.69% 95 Inventories, Work In Process is ₹0 Mil as of Jun. 2026. GuruFocus rates BOM:532331 with a GF Score™ of 95/100 and a GF Value™ of ₹3,348.50 (Fairly Valued). The stock has 6 warning signs investors should review.

Work in process is the part of a manufacturer's inventory that is in the production process and has not yet been completed and transferred to the finished goods inventory. Ajanta Pharma's work in process for the quarter that ended in Jun. 2026 was ₹0 Mil.

Ajanta Pharma Inventories, Work In Process Historical Data

* Premium members only.

The historical data trend for Ajanta Pharma's Inventories, Work In Process can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ajanta Pharma Inventories, Work In Process Chart

Ajanta Pharma Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Inventories, Work In Process
Get a 7-Day Free Trial Premium Member Only Premium Member Only 465.00 524.60 543.50 455.50 645.20

Ajanta Pharma Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Inventories, Work In Process Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 645.20 0.00
BOM:532331
95GF Score
Ajanta Pharma Ltd BOM:532331
Inventories, Work In Process is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ajanta Pharma Inventories, Work In Process Calculation

That part of a manufacturer's inventory that is in the production process and has not yet been completed and transferred to the finished goods inventory. This account contains the cost of the direct material, direct labor, and factory overhead placed into the products on the factory floor. A manufacturer must disclose in its financial statements the cost of its work-in-process as well as the cost of finished goods and materials on hand.

What does a Inventories, Work In Process of ₹0 Mil mean?
Ajanta Pharma (BOM:532331) has a Inventories, Work In Process of ₹0 Mil as of Jun. 2026. Work in progress is the portion of inventory containing goods that are unfinished. View historical data on Ajanta Pharma and its competitors.
Is Ajanta Pharma's Inventories, Work In Process too high?
Ajanta Pharma's current Inventories, Work In Process is ₹0 Mil. Overall, Ajanta Pharma has a GF Score™ of 95/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Ajanta Pharma's Inventories, Work In Process compare to ZTS?
Ajanta Pharma's Inventories, Work In Process of ₹0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Work In Process for a Drug Manufacturers company?
A good Inventories, Work In Process depends on the Drug Manufacturers industry context. However, Inventories, Work In Process should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Work In Process mean?
A high Inventories, Work In Process can signal that a stock is expensive relative to its fundamentals. Work in progress is the portion of inventory containing goods that are unfinished. View historical data on Ajanta Pharma and its competitors. Ajanta Pharma's current Inventories, Work In Process is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ajanta Pharma stock overvalued right now?
Based on GuruFocus' analysis, Ajanta Pharma (BOM:532331) is currently considered Fairly Valued. The stock's GF Value™ is ₹3,348.50, compared to a current price of ₹3,480.95 — trading 4% above its estimated fair value. The current Inventories, Work In Process is ₹0 Mil. Ajanta Pharma's overall GF Score™ is 95/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Work In Process calculated?
Inventories, Work In Process is calculated from a company's financial statements. For Ajanta Pharma (BOM:532331), the current Inventories, Work In Process is ₹0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ajanta Pharma (BOM:532331) Overvalued in 2026?

Based on GuruFocus' analysis, Ajanta Pharma stock appears to be overvalued. The current stock price of ₹3,480.95 is trading 4% above its estimated GF Value™ of ₹3,348.50. GuruFocus considers Ajanta Pharma to be Fairly Valued.

Key valuation signals for BOM:532331:

  • Inventories, Work In Process: ₹0 Mil
  • GF Value™: ₹3,348.50 vs. price of ₹3,480.95 (4% above fair value)
  • GF Score™: 95/100 with 6 warning signs

No single metric tells the full story. See the BOM:532331 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ajanta Pharma Business Description

Other Exchanges AJANTPHARM:India
Address M Vasanji Road, Ajanta Tower, 54-A, Chakala, Andheri East, Mumbai, MH, IND, 400 093
Ajanta Pharma Ltd is mainly involved in development, manufacturing and marketing of speciality pharmaceutical finished dosages. The operations of the Group are limited to only one segment viz. pharmaceuticals and related products. The company has presence in India, Emerging Market, Africa Institution, and USA. The company generates majority of revenue from Emerging market.
95GF Score

Get the complete analysis for BOM:532331

Inventories, Work In Process is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹3,480.95
Price
₹3,348.50
GF Value